(Q43193920)

15 November 2017

Candesartan effect on inflammation in hypertension (English)

1 reference

15 November 2017

0 references

1

1 reference

15 November 2017

2

1 reference

15 November 2017

8

1 reference

15 November 2017

9

1 reference

15 November 2017

3

Sibilla A T Salvadeo

1 reference

15 November 2017

4

Ilaria Ferrari

1 reference

15 November 2017

5

Alessia Gravina

1 reference

15 November 2017

6

Roberto Mereu

1 reference

15 November 2017

7

Ilaria Palumbo

1 reference

15 November 2017

15 January 2010

1 reference

15 November 2017

Hypertension Research

1 reference

15 November 2017

33

1 reference

15 November 2017

3

1 reference

15 November 2017

209-213

1 reference

https://scigraph.springernature.com/pub.10.1038/hr.2009.212

15 November 2017

0 references

cites work

The pathology of atherosclerosis: plaque development and plaque responses to medical treatment

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

Insulin resistance and blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

Inflammation and the metabolic syndrome: role of angiotensin II and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

Relationship between insulin resistance and inflammatory markers and anti-inflammatory effect of losartan in patients with type 2 diabetes and hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

Vascular benefits of angiotensin receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

Peroxisome proliferator-activated receptor alpha polymorphisms and postprandial lipemia in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

Determination of total serum insulin (IRI) in insulin-treated diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

Analysis of serial measurements in medical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

Lipoprotein remnants and endothelial dysfunction in the postprandial phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

Recent findings in the study of postprandial lipemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

Postprandial inflammation and endothelial dysfuction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

Effects of oxidative stress on endothelial function after a high-fat meal

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

Anti-inflammatory and metabolic effects of candesartan in hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

Candesartan suppresses chronic renal inflammation by a novel antioxidant action independent of AT1R blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

Long-term, high-dosage candesartan suppresses inflammation and injury in chronic kidney disease: nonhemodynamic renal protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

Postprandial lipoproteins and progression of coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

Post-prandial endothelial dysfunction in hypertriglyceridemic subjects: Molecular mechanisms and gene expression studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

7 January 2021

Beneficial effects of angiotensin II type 1 receptor blocker antihypertensive treatment on inflammation indices: the effect of smoking

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

7 January 2021

The differential effects of angiotensin II type 1 receptor blockers on microalbuminuria in relation to low-grade inflammation in metabolic hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

7 January 2021

Triglycerides and risk for coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

7 January 2021

Nonfasting Triglycerides and Risk of Myocardial Infarction, Ischemic Heart Disease, and Death in Men and Women

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

7 January 2021

Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

7 January 2021

Activation of coagulation factor VII during alimentary lipemia.

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

7 January 2021

Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2009.212

7 January 2021

Identifiers

DOI

10.1038/HR.2009.212

1 reference

PubMed ID

20075928

Dimensions Publication ID

15 November 2017

0 references

1 reference

PubMed ID

20075928